NTLA : Intellia Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-09-30 |
|---|---|---|---|---|
| 2022 | $61.38 | $59.13 | $63.63 | 9.69% |
| 2023 | $61.29 | $57.22 | $67.07 | 9.53% |
| 2024 | $56.5 | $54.33 | $58.91 | 0.96% |
| 2025 | $52.58 | $49.37 | $53.65 | -6.03% |
| 2026 | $46.51 | $43.3 | $50.51 | -16.89% |
| 2027 | $38.76 | $36.56 | $41.73 | -30.73% |
| 2028 | $33.46 | $31.76 | $36.84 | -40.2% |
| 2029 | $45.49 | $33.82 | $51.43 | -18.71% |
| 2030 | $57.33 | $52.39 | $61.08 | 2.45% |
| 2031 | $66.84 | $61.34 | $73.8 | 19.43% |
| 2032 | $76.37 | $74.4 | $80.78 | 36.48% |
The 10 Wall Street analysts offering Intellia Therapeutics stock forecast in the last 6 months have average price target of
$114.5 with a high forecast of $180.0 and a low forecast of $54.0.
The average Intellia Therapeutics stock forecast represents a 104.61%
increase from the last price of $55.9599990844727.
From AI system, total return is 2451.47% from 4062 forecasts.
For Intellia Therapeutics stock forecast for 2022, 2 predictions are offered for each month of 2022 with average Intellia Therapeutics stock
forecast of $61.38, a high forecast of $63.63, and a low forecast of $59.13.
The average Intellia Therapeutics stock forecast 2022 represents a 9.69%
increase from the last price of $55.9599990844727.
For Intellia Therapeutics stock forecast for 2023, 12 predictions are offered for each month of 2023 with average Intellia Therapeutics stock
forecast of $61.29, a high forecast of $67.07, and a low forecast of $57.22.
The average Intellia Therapeutics stock forecast 2023 represents a 9.53%
increase from the last price of $55.9599990844727.
For Intellia Therapeutics stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Intellia Therapeutics stock
forecast of $52.58, a high forecast of $53.65, and a low forecast of $49.37.
The average Intellia Therapeutics stock forecast 2025 represents a -6.03%
decrease from the last price of $55.9599990844727.
For Intellia Therapeutics stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Intellia Therapeutics stock
forecast of $38.76, a high forecast of $41.73, and a low forecast of $36.56.
The average Intellia Therapeutics stock forecast 2027 represents a -30.73%
decrease from the last price of $55.9599990844727.
For Intellia Therapeutics stock forecast for 2030, 12 predictions are offered for each month of 2030 with average Intellia Therapeutics stock
forecast of $57.33, a high forecast of $61.08, and a low forecast of $52.39.
The average Intellia Therapeutics stock forecast 2030 represents a 2.45%
increase from the last price of $55.9599990844727.
For Intellia Therapeutics stock forecast for 2032 (10 year), 10 predictions are offered for each month of 2032 with average Intellia Therapeutics stock
forecast of $76.37, a high forecast of $80.78, and a low forecast of $74.4.
The average Intellia Therapeutics stock forecast 2032 represents a 36.48%
increase from the last price of $55.9599990844727.
Please, see more forecasts below.
NTLA : Intellia Therapeutics stock forecast by Wall Street Analysts
The average Intellia Therapeutics stock forecast from last 6 month is $114.5, and this show a -19.14% decrease in average from the prior price target of the each prediction. Also, this average forecast of $114.5 represents a -26.48% decrease from the past average forecast of $155.75, 6 months ago from 8 wall street analysts.
Intellia Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-10-03 | $54.00 | -3.49% |
| 2022-10-04 | $48.29 | -10.58% |
| 2022-10-05 | $44.56 | -7.72% |
| 2022-10-06 | $50.16 | 12.56% |
| 2022-10-07 | $55.73 | 11.11% |
NTLA : Long term Intellia Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Nov. is $59.13 , for 2023 Oct. is $60.06 , for 2026 Oct. is $44.93 , for 2027 Oct. is $36.56 , for 2031 Oct. is $71.82 , and for 2032 Oct. is $80.78.
NTLA : Intellia Therapeutics stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Nov. | $59.13 | 5.67% |
| 2022 Dec. | $63.63 | 7.61% |
NTLA : Intellia Therapeutics stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $66.80 | 4.99% |
| 2023 Feb. | $67.07 | 0.40% |
| 2023 Mar. | $64.46 | -3.90% |
| 2023 Apr. | $60.46 | -6.19% |
| 2023 May. | $57.76 | -4.47% |
| 2023 Jun. | $58.60 | 1.46% |
| 2023 Jul. | $60.79 | 3.72% |
| 2023 Aug. | $62.31 | 2.51% |
| 2023 Sep. | $61.96 | -0.57% |
| 2023 Oct. | $60.06 | -3.06% |
| 2023 Nov. | $58.02 | -3.40% |
| 2023 Dec. | $57.22 | -1.38% |
NTLA : Intellia Therapeutics stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $57.79 | 1.00% |
| 2024 Feb. | $58.70 | 1.58% |
| 2024 Mar. | $58.91 | 0.36% |
| 2024 Apr. | $58.12 | -1.36% |
| 2024 May. | $56.75 | -2.35% |
| 2024 Jun. | $55.59 | -2.04% |
| 2024 Jul. | $55.21 | -0.68% |
| 2024 Aug. | $55.59 | 0.69% |
| 2024 Sep. | $55.96 | 0.65% |
| 2024 Oct. | $55.84 | -0.21% |
| 2024 Nov. | $55.18 | -1.17% |
| 2024 Dec. | $54.33 | -1.55% |
NTLA : Intellia Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $53.65 | -1.24% |
| 2025 Feb. | $53.32 | -0.63% |
| 2025 Mar. | $53.29 | -0.04% |
| 2025 Apr. | $53.37 | 0.15% |
| 2025 May. | $53.27 | -0.19% |
| 2025 Jun. | $53.35 | 0.14% |
| 2025 Jul. | $53.38 | 0.06% |
| 2025 Aug. | $52.99 | -0.72% |
| 2025 Sep. | $52.33 | -1.25% |
| 2025 Oct. | $51.87 | -0.89% |
| 2025 Nov. | $50.79 | -2.07% |
| 2025 Dec. | $49.37 | -2.80% |
NTLA : Intellia Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $48.07 | -2.63% |
| 2026 Feb. | $48.25 | 0.37% |
| 2026 Mar. | $49.83 | 3.28% |
| 2026 Apr. | $50.51 | 1.35% |
| 2026 May. | $49.28 | -2.43% |
| 2026 Jun. | $46.93 | -4.78% |
| 2026 Jul. | $44.47 | -5.25% |
| 2026 Aug. | $43.61 | -1.92% |
| 2026 Sep. | $44.31 | 1.59% |
| 2026 Oct. | $44.93 | 1.41% |
| 2026 Nov. | $44.61 | -0.72% |
| 2026 Dec. | $43.30 | -2.93% |
NTLA : Intellia Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $41.73 | -3.62% |
| 2027 Feb. | $40.57 | -2.79% |
| 2027 Mar. | $39.98 | -1.45% |
| 2027 Apr. | $39.76 | -0.56% |
| 2027 May. | $39.57 | -0.48% |
| 2027 Jun. | $39.19 | -0.94% |
| 2027 Jul. | $38.53 | -1.70% |
| 2027 Aug. | $37.68 | -2.19% |
| 2027 Sep. | $36.92 | -2.04% |
| 2027 Oct. | $36.56 | -0.97% |
| 2027 Nov. | $37.07 | 1.41% |
| 2027 Dec. | $37.59 | 1.38% |
NTLA : Intellia Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $36.84 | -1.97% |
| 2028 Feb. | $35.66 | -3.22% |
| 2028 Mar. | $34.65 | -2.82% |
| 2028 Apr. | $33.99 | -1.90% |
| 2028 May. | $33.80 | -0.56% |
| 2028 Jun. | $33.43 | -1.10% |
| 2028 Jul. | $32.89 | -1.61% |
| 2028 Aug. | $32.37 | -1.58% |
| 2028 Sep. | $31.98 | -1.21% |
| 2028 Oct. | $31.76 | -0.67% |
| 2028 Nov. | $31.81 | 0.14% |
| 2028 Dec. | $32.35 | 1.69% |
NTLA : Intellia Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $33.82 | 4.54% |
| 2029 Feb. | $36.66 | 8.42% |
| 2029 Mar. | $40.61 | 10.76% |
| 2029 Apr. | $44.14 | 8.70% |
| 2029 May. | $46.34 | 4.97% |
| 2029 Jun. | $47.40 | 2.29% |
| 2029 Jul. | $47.91 | 1.07% |
| 2029 Aug. | $48.37 | 0.97% |
| 2029 Sep. | $48.98 | 1.25% |
| 2029 Oct. | $49.70 | 1.48% |
| 2029 Nov. | $50.53 | 1.67% |
| 2029 Dec. | $51.43 | 1.79% |
NTLA : Intellia Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $52.39 | 1.86% |
| 2030 Feb. | $53.41 | 1.95% |
| 2030 Mar. | $54.48 | 2.01% |
| 2030 Apr. | $55.55 | 1.96% |
| 2030 May. | $56.55 | 1.79% |
| 2030 Jun. | $57.38 | 1.48% |
| 2030 Jul. | $57.99 | 1.05% |
| 2030 Aug. | $58.74 | 1.30% |
| 2030 Sep. | $59.51 | 1.31% |
| 2030 Oct. | $60.19 | 1.15% |
| 2030 Nov. | $60.71 | 0.86% |
| 2030 Dec. | $61.08 | 0.61% |
NTLA : Intellia Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $61.34 | 0.42% |
| 2031 Feb. | $61.47 | 0.21% |
| 2031 Mar. | $61.54 | 0.11% |
| 2031 Apr. | $61.98 | 0.73% |
| 2031 May. | $63.49 | 2.43% |
| 2031 Jun. | $65.86 | 3.73% |
| 2031 Jul. | $67.94 | 3.15% |
| 2031 Aug. | $69.34 | 2.07% |
| 2031 Sep. | $70.47 | 1.62% |
| 2031 Oct. | $71.82 | 1.93% |
| 2031 Nov. | $72.98 | 1.61% |
| 2031 Dec. | $73.80 | 1.12% |
NTLA : Intellia Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $74.40 | 0.82% |
| 2032 Feb. | $74.79 | 0.52% |
| 2032 Mar. | $74.98 | 0.25% |
| 2032 Apr. | $74.99 | 0.01% |
| 2032 May. | $75.01 | 0.03% |
| 2032 Jun. | $75.45 | 0.59% |
| 2032 Jul. | $76.41 | 1.28% |
| 2032 Aug. | $77.72 | 1.71% |
| 2032 Sep. | $79.21 | 1.91% |
| 2032 Oct. | $80.78 | 1.98% |
Financial Data for Intellia Therapeutics stock
Frequently Asked Questions about Intellia Therapeutics stock forecast
Is Intellia Therapeutics a good long term stock?
From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2022 Nov. is $59.1339856691838 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2023 Oct. is $60.0638481721285 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2026 Oct. is $44.9316319712648 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2027 Oct. is $36.5590210269003 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2031 Oct. is $71.8239933648522 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AI Pickup, the Intellia Therapeutics stock price forecast for 2032 Oct. is $80.7764062486646
Is Intellia Therapeutics stock overvalued?
Intellia Therapeutics (NTLA) stock is expected to go UP . Therefore, AI Pickup would say that Intellia Therapeutics (NTLA) stock is NOT overvalued.
Will Intellia Therapeutics stock price go up?
Yes. The Intellia Therapeutics stock price forecast for 2023 Oct. is $60.0638481721285
Is Intellia Therapeutics stock a good buy now?
Since closing price on 2022-09-30 is $55.9599990844727 and forecast for 2023 Oct. is $60.06, Intellia Therapeutics stock is a good 1 year investment.